HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) All Versions of this Article: ps.052015606v1 15/4/837    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Runquist, J. A. Articles by Miziorko, H. M. Search for Related Content PubMed PubMed Citation Articles by Runquist, J. A. Articles by Miziorko, H. M. Social Bookmarking                   What's this?

Research Article

Functional contribution of a conserved, mobile loop histidine of phosphoribulokinase

¹ Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
² Division of Molecular Biology and Biochemistry, University of Missouri—Kansas City, Kansas City, Missouri 64110, USA

(RECEIVED December 6, 2005; FINAL REVISION December 27, 2005; ACCEPTED December 27, 2005)

In the Rhodobacter sphaeroides phosphoribulokinase (PRK) structure, there are several disordered regions, including a loop containing invariant residues Y98 and H100. The functional importance of these residues has been unclear. PRK is inactivated by diethyl pyrocarbonate (DEPC) and protected by the substrates ATP and Ru5P, as well as by the competitive inhibitor, 6-phosphogluconate, suggesting active site histidine residue(s). PRK contains only three invariant histidines: H45, H100, and H134. Previous mutagenesis studies discount significant function for H134, but implicate H45 in Ru5P binding. PRK mutant H45N is inactivated by DEPC, implicating a second active site histidine. To evaluate the function of H100, as well as another invariant loop residue Y98, PRK mutants Y98L, H100A, H100N, and H100Q were characterized. Mutant PRK binding stoichiometries for the fluorescent alternative substrate, trinitrophenyl-ATP, as well as the allosteric activator, NADH, are comparable to wild-type PRK values, suggesting intact effector and substrate binding sites. The K_mRu5P for the H100 mutants shows modest eight- to 14-fold inflation effects, whereas Y98L exhibits a 40-fold inflation for K_mRu5P. However, Y98L’s K_i for the competitive inhibitor 6-phosphogluconate is close to that of wild-type PRK. These observations suggest that Y98 and H100 are not essential Ru5P binding determinants. The Vm of Y98L is diminished 27-fold compared with wild-type PRK. In contrast, H100A, H100N, and H100Q exhibit significant decreases in Vm of 2600-, 2300-, and 735- fold, respectively. Results suggest that the mobile region containing Y98 and H100 must contribute to PRK’s active site. Moreover, H100’s imidazole significantly influences catalytic efficiency.

Keywords: phosphoribulokinase; phosphotransferases; Calvin cycle; site-directed mutagenesis; histidine

Abbreviations: DEPC, diethyl pyrocarbonate; DTT, dithiothreitol; IPTG, isopropyl -D-1-thiogalactopyranoside; PRK, phosphoribulokinase; Ru5P, ribulose 5-phosphate; RuBP, ribulose 1,5-bisphosphate; 6-PG, 6-phosphogluconate; TNP-ATP, 2(3)-O-(2,4,6-trinitrophenol) adenosine 5-triphosphate; NADH, -nicotinamide adenine dinucleotide reduced form.

Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.052015606

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. E. Caldwell, M. R. MacLean, and P. R. Norris Ribulose bisphosphate carboxylase activity and a Calvin cycle gene cluster in Sulfobacillus species Microbiology, July 1, 2007; 153(7): 2231 - 2240. [Abstract] [Full Text] [PDF]